2020年上海市科學技術獎提名公示(2)

國別

知識產權類別

授權號

名稱

發明人

核心專利

中國

發明專利

CN101750502A

一種同步檢測AFP和AFP-IgM的TRFIA及其試劑盒

盛世樂;黃鋼;王青

是

中國

發明專利

CN100418966C

8－碘代咪唑並［1,2－a］吡啶－3－乙酰胺類化合物及製備方法

黃鋼;李斌

是

中國

實用新型專利

CN203613193U

一種細胞代謝與呼吸的動態檢測裝置

黃鋼;周翔;苗平

是

中國

實用新型專利

CN201501875U

恒流培養裝置及使用其的γ射線動態監測裝置

黃鋼;盛世樂;宋少莉

是

中國

計算機軟件著作權

2014SR081799

PET/CT診斷孤立性肺結節的智能軟件V1.0

陳虞梅

是

序號

論文著作

通訊作者

引用次數

1

Zhu Zongping, Zhao Xiaoping, Zhao Li, Yang Hao, Liu Liu, Li Jiajin, Wu Jianguo, Yang Fajun, Huang Gang, Liu Jianjun.p54(nrb)/NONO regulates lipid metabolism and breast cancer growth throughSREBP-1A [J]. Oncogene, 2016, 35(11): 1399-1410.

劉建軍，黃鋼

20

2

Huang Liangqian, Yu Zhenhai, Zhang Zhenchao, Ma Wenjing, Song Shaoli, Huang Gang. Interaction with PyruvateKinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and RegulatesCell Proliferation in Breast Cancer [J]. Scientific Reports, 2016, 6: 22449.

黃鋼

14

3

Liu Qiufang, Zhou Min, Li Panli, Ku Geng, Huang Gang, Li Chun, Song Shaoli. (64) CuS-labelednanoparticles: a new sentinel-lymph-node-mapping agent for PET-CT andphotoacoustic tomography [J]. Contrast Media & Molecular Imaging, 2016, 11(6): 475-481.

宋少莉

5

4

Xin Mei, Qiao Zhiguang, Li Jing, Liu Jianjun, Song Shaoli, Zhao Xiaoping, Miao Ping, Tang Tingtin, Wang Lei), Liu Weichun, Yang Xiaodi, Dai Kerong, Huang Gang. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer andlung cancer [J]. Oncotarget, 2016, 7(28): 44252-44265.

黃鋼，戴尅戎

64

5

Yang Hao, Zhao Xiaoping, Zhao Li, Liu Liu, Li Jiajin, Jia Wenzhi, Liu Jianjun, Huang Gang. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma [J]. Oncotarget, 2016, 7(44): 72131-72147.

黃鋼

10

6

Tang Shuang, Huang Gang, Fan Wei,  Chen Yue, Ward James M., Xu Xiaojiang, Xu Qing, Kang Ashley, McBurney Michael W., Fargo David C., Hu Guang, Baumgart-Vogt Eveline,  Zhao Yingming, Li Xiaoling. SIRT1-mediated deacetylation ofCRABPII regulates cellular retinoic acid signaling and modulates embryonic stemcell differentiation [J]. Molecular Cell, 2014, 55(6): 843-855.

黃鋼，Li Xiaoling

32

7

Zhou Xiang, Chen Ruohua, Xie Wenhui, Ni Yicheng, Liu Jianjun, Huang Gang. Relationship between 18F-FDGaccumulation and lactate dehydrogenase A expression in lung adenocarcinomas [J]. Journal of Nuclear Medicine, 2014, 55(11): 1766-1771.

黃鋼，劉建軍

30

8

Huang Liangqian, Yu Zhenhai, Zhang Teng, Zhao Xiaoping, Huang Gang. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells [J]. PLoS One, 2014, 9(3): e92949.

黃鋼

19

9

Yu Zhenhai, Ge Yingying, Xie Lei, Zhang Teng, Huang Liangqian, Zhao Xiaoping, Liu Jianjun, Huang Gang. Using a yeasttwo-hybrid system to identify FTCD as a new regulator for HIF-1α in HepG2 cells [J]. Cellular Signalling, 2014, 26(7): 1560-1566.

黃鋼

10

10

Yu Zhenhai, Zhao Xiaoping, Huang Liangqian, Zhang Teng, Yang Fajun, Xie Lei, Song Shaoli, Miao Ping, Zhao Li, Sun Xiaoguang, Liu Jianjun, Huang Gang. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells [J].Journal of Biological Chemistry, 2013, 288(49): 35406-35416.

黃鋼🐶，劉建軍

44

11

Liu Yewei, Xie Reuben Qian, Wang Boshi, Shao Jiaxiang, Zhang Tingting, Liu Tengyuan, Huang Gang，Xia Weiliang. Inhibition ofSIRT6 in prostate cancer reduces cell viability and increases sensitivity tochemotherapeutics [J]. Protein Cell, 2013, 4(9): 702-710.

夏偉梁，黃鋼

45

12

Miao Ping, Sheng Shile, Sun Xiaoguang, Liu Jianjun, Huang Gang. Lactate dehydrogenase A in cancer: apromising target for diagnosis and therapy [J]. IUBMB Life, 2013, 65(11): 904-910.

黃鋼

146

13

Zhang Chenpeng, Tong Jinlu, Huang Gang. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells [J]. PLoS One, 2013, 8(7): e69963.

黃鋼

34

14

Song Shaoli, Xiong Chiyi, Lu Wei, Ku Geng, Huang Gang, Li Chun. Apoptosis imaging probe predictsearly chemotherapy response in preclinical models: A comparative study with18F-FDG PET[J]. Journal of Nuclear Medicine, 2013, 54(1):104-110.

李春，黃鋼

25

15

Ding Gang, Liu He-Dai, Huang Qian, Liang Hong-Xiang, Ding Zhao-Han, Liao Zhi-Jun, Huang Gang. HDAC6 promoteshepatocellular carcinoma progression by inhibiting P53 transcriptional activity [J]. FEBS Letters. 2013, 587(7): 880-886.

黃鋼

40

16

Sheng Shi L., Liu Jian J., Dai Yun H., Sun Xiao G., Xiong Xiao P., Huang Gang. Knockdown of lactatedehydrogenase A suppresses tumor growth and metastasis of human hepatocellularcarcinoma [J]. FEBS Journal, 2012, 279(20): 3898-3910.

黃鋼

118

17

Wang Yuting, Zhang Chengpeng, Liu Jianjun, Huang Gang. Is 18F-FDG PET accurate to predictneoadjuvant therapy response in breast cancer? A meta-analysis [J]. Breast Cancer Research and Treatment, 2012, 131(2): 357-369.

黃鋼

75

18

Tang Shuang, Huang Gang, Liu Jianjun, Liu Tao, Treven Lyndal, Song Saoli, Zhang Chenpeng, Pan Lingling, Zhang Ting. Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primarypancreatic carcinoma: a meta-analysis [J]. European Journal of Radiology,2011, 78(1): 142-150.

黃鋼

59

19

Chen Yumei, Huang Gang, Sun Xiao Guang, Liu Jian Jun, Chen Tao, Shi Yi Ping, Wan Liang Rong. Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan [J]. Nuclear Medicine Communications, 2008, 29(5): 425‐430.

黃鋼

26

20

Song Shao-Li, Liu Jian-Jun, Huang Gang, Wang Zhao-Hai, Song Yan-Yan, Sun Xiao-Guang, Chen Tao. Changes in 18F-FDGuptake within minutes after chemotherapy in a rabbit VX2 tumor model [J]. Journal of Nuclear Medicine,2008, 49(2): 303-309.

黃鋼

33